These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 6392348

  • 1. Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
    Heyderman E, Brown BM, Richardson TC.
    J Clin Pathol; 1984 Dec; 37(12):1363-9. PubMed ID: 6392348
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
    Takashi M, Murase T, Mitsuya H, Koshikawa T, Nagura H, Haimoto H.
    Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Origin of carcinomas causing bladder neck obstruction demonstrated by immunoperoxidase localisation of specific antigens.
    Al Adnani MS.
    Br J Urol; 1986 Jun; 58(3):283-6. PubMed ID: 3521781
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunoperoxidase localization of carcinoembryonic antigen in benign and malignant colorectal tumors and related mucosa.
    Stenger RJ, Chabon AB, Primus FJ, Wolff WI.
    Mt Sinai J Med; 1979 Jun; 46(2):185-9. PubMed ID: 375071
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
    Friedmann W, Steffens J, Lobeck H, Blümcke S, Nagel R.
    Eur Urol; 1985 Jun; 11(1):52-6. PubMed ID: 2580711
    [Abstract] [Full Text] [Related]

  • 13. Immunostaining of carcinoembryonic antigen in colorectal adenocarcinomas and polyps.
    Lascano EF, Patitó JA, Salama AA, Garriz R.
    Medicina (B Aires); 1979 Jun; 39(3):369-74. PubMed ID: 390298
    [No Abstract] [Full Text] [Related]

  • 14. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
    Mai KT, Yazdi HM, Farmer J.
    Prostate; 2001 May 15; 47(3):172-82. PubMed ID: 11351346
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tumor markers in colorectal carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
    Rasmuson T, Björk GR, Damber L, Holm SE, Jacobsson L, Jeppsson A, Stigbrand T, Westman G.
    Acta Radiol Oncol; 1984 May 15; 23(1):27-32. PubMed ID: 6328884
    [Abstract] [Full Text] [Related]

  • 18. Biological markers in prostate cancer.
    Pontes JE.
    J Urol; 1983 Dec 15; 130(6):1037-47. PubMed ID: 6196490
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.